about
Effects of hexagonal boron nitride on dry compression mixture of Avicel DG and Starch 1500.Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets.Quality by design (QbD) approaches for the compression step of tableting.Impact of excipient interactions on solid dosage form stability.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering.The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.Galenic approaches in troubleshooting of glibenclamide tablet adhesion in compression machine punches.The effect of lubricants on powder flowability for pharmaceutical application.Image analysis quantification of sticking and picking events of pharmaceutical powders compressed on a rotary tablet press simulator.Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior.Measurement of flowability of lubricated powders by the vibrating tube method.Lubricant sensitivity in function of paddle movement in the forced feeder of a high-speed tablet press.Sustained release of diltiazem HCl tableted after co-spray drying and physical mixing with PVAc and PVP.A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets.Investigating critical effects of variegated lubricants, glidants and hydrophilic additives on lag time of press coated ethylcellulose tablets.Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach
P2860
Q35567845-5BFAA0B4-BC43-497A-9F43-FA5082DDA754Q37174997-D821698B-1D28-4305-AA4B-EFE178C21F3BQ37957958-28154AA8-5F12-40F5-BE6E-D83AFB334BC5Q38019469-8DFD9F73-0FC0-4C27-812C-86FEB97BB84FQ38242752-CF4FC2B7-1FA3-4375-8A2B-3545B0015823Q39630255-FDF02566-AAC9-4A6D-B341-4E442C3A18F7Q40507032-B84C1CE7-5106-4AB4-ABD6-AA4F460A00CFQ41729236-EF781217-D0B0-4DF4-8C03-547C490A32B9Q42574242-18E3B511-17FC-4D2A-B8EC-518828B01A66Q46816961-AE87765D-36DF-4C59-9434-C1CD2525ACB8Q46835371-64D8758C-0A84-4AAD-A449-CC087E528E67Q46943752-0B0F8FC2-D5FD-4BB2-8AEB-37DD7FE2C877Q49043976-C11EA671-F22F-4BE8-9543-C47A25590AD5Q50905391-510B969D-E22D-4EE5-B395-683E8131ED81Q51420307-C4CA7BCD-B1A4-4CA8-B459-BED56876FD23Q53345478-46BAD0E0-4F74-4B54-B30E-072EF8B4CC83Q58730462-D33E35D1-11F6-4962-A370-EFDF908C56CC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lubrication in tablet formulations.
@en
Lubrication in tablet formulations.
@nl
type
label
Lubrication in tablet formulations.
@en
Lubrication in tablet formulations.
@nl
prefLabel
Lubrication in tablet formulations.
@en
Lubrication in tablet formulations.
@nl
P2093
P1476
Lubrication in tablet formulations.
@en
P2093
Divyakant Desai
Jennifer Wang
P356
10.1016/J.EJPB.2010.01.007
P407
P577
2010-01-22T00:00:00Z